Patent AnalyticsExaminers
Rankings

Company or institution

ANIONA APS

40 applicationsfiled 2006 to 2014

Allowance rate
95%
+20 pts vs the USPTO range 84% to 99%
Rejections before allowance
1.2
−0.4 vs the USPTO
Months to first action
20.3 mo
+1.7 vs the USPTO
Needed an RCE
5%
−22 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07D Heterocyclic compounds38 apps
C07C 1 apps
A61P Therapeutic activity of compounds1 apps

Art units

162414 apps
16255 apps
16214 apps
16264 apps
16914 apps
16283 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
14263664CHROMEN-2-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INH…2014-04-28Allowed101.1 mo
13575712CHROMEN-2-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INH…2012-10-12Abandoned107.7 mo
13129186BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABAA RECEPTOR COMPLEX2011-07-07Abandoned1018.2 mo
15912971Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15423422Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15348376Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15437838Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15860273Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15844322Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15727510Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 40 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in